|
US4946929A
(en)
|
1983-03-22 |
1990-08-07 |
Massachusetts Institute Of Technology |
Bioerodible articles useful as implants and prostheses having predictable degradation rates
|
|
US6309669B1
(en)
*
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
|
US4638045A
(en)
|
1985-02-19 |
1987-01-20 |
Massachusetts Institute Of Technology |
Non-peptide polyamino acid bioerodible polymers
|
|
US4806621A
(en)
|
1986-01-21 |
1989-02-21 |
Massachusetts Institute Of Technology |
Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
|
|
US5759830A
(en)
|
1986-11-20 |
1998-06-02 |
Massachusetts Institute Of Technology |
Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
|
|
CA1340581C
(en)
|
1986-11-20 |
1999-06-08 |
Joseph P. Vacanti |
Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
|
|
US5736372A
(en)
|
1986-11-20 |
1998-04-07 |
Massachusetts Institute Of Technology |
Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
|
|
US5912017A
(en)
*
|
1987-05-01 |
1999-06-15 |
Massachusetts Institute Of Technology |
Multiwall polymeric microspheres
|
|
US5019379A
(en)
|
1987-07-31 |
1991-05-28 |
Massachusetts Institute Of Technology |
Unsaturated polyanhydrides
|
|
US6130082A
(en)
|
1988-05-05 |
2000-10-10 |
American Cyanamid Company |
Recombinant flagellin vaccines
|
|
US5180806A
(en)
*
|
1988-05-16 |
1993-01-19 |
The Scripps Research Institute |
Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods
|
|
US5010167A
(en)
|
1989-03-31 |
1991-04-23 |
Massachusetts Institute Of Technology |
Poly(amide-and imide-co-anhydride) for biological application
|
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
GB9113809D0
(en)
*
|
1991-06-26 |
1991-08-14 |
Cancer Res Campaign Tech |
Papillomavirus l2 protein
|
|
DK0671948T3
(da)
*
|
1992-06-25 |
1997-09-01 |
Smithkline Beecham Biolog |
Vaccinepræparat indeholdende adjuvanser
|
|
US6337070B1
(en)
*
|
1993-04-29 |
2002-01-08 |
Takara Shuzo Co., Ltd. |
Polypeptides for use in generating anti-human influenza virus antibodies
|
|
US5399665A
(en)
|
1992-11-05 |
1995-03-21 |
Massachusetts Institute Of Technology |
Biodegradable polymers for cell transplantation
|
|
EP0678034B1
(en)
*
|
1993-01-11 |
1999-05-26 |
Dana Farber Cancer Institute |
Inducing cytotoxic t lymphocyte responses
|
|
US5512600A
(en)
|
1993-01-15 |
1996-04-30 |
Massachusetts Institute Of Technology |
Preparation of bonded fiber structures for cell implantation
|
|
US5514378A
(en)
|
1993-02-01 |
1996-05-07 |
Massachusetts Institute Of Technology |
Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
|
|
WO1995003035A1
(en)
*
|
1993-07-23 |
1995-02-02 |
Massachusetts Institute Of Technology |
Polymerized liposomes with enhanced stability for oral delivery
|
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US6485729B1
(en)
*
|
1993-09-13 |
2002-11-26 |
Protein Sciences Corporation |
Neuraminidase-supplemented compositions
|
|
AUPM358894A0
(en)
*
|
1994-01-31 |
1994-02-24 |
Csl Limited |
Modified papilloma virus l2 protein and vlps formed therefrom
|
|
US5693325A
(en)
*
|
1994-03-15 |
1997-12-02 |
Molecumetics, Ltd. |
Peptide vaccines and methods relating thereto
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
GB9420146D0
(en)
*
|
1994-10-06 |
1994-11-23 |
Cancer Res Campaign Tech |
Papillomavirus vaccine
|
|
US5716404A
(en)
|
1994-12-16 |
1998-02-10 |
Massachusetts Institute Of Technology |
Breast tissue engineering
|
|
US6123727A
(en)
|
1995-05-01 |
2000-09-26 |
Massachusetts Institute Of Technology |
Tissue engineered tendons and ligaments
|
|
US5866132A
(en)
*
|
1995-06-07 |
1999-02-02 |
Alberta Research Council |
Immunogenic oligosaccharide compositions
|
|
US6095148A
(en)
|
1995-11-03 |
2000-08-01 |
Children's Medical Center Corporation |
Neuronal stimulation using electrically conducting polymers
|
|
US5902599A
(en)
|
1996-02-20 |
1999-05-11 |
Massachusetts Institute Of Technology |
Biodegradable polymer networks for use in orthopedic and dental applications
|
|
US6946133B1
(en)
*
|
1996-03-20 |
2005-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Prostate specific antigen oligo-epitope peptide
|
|
JP2000515741A
(ja)
*
|
1996-07-17 |
2000-11-28 |
アメリカ合衆国 |
感染性パピローマウイルス偽ウイルス粒子
|
|
JP2000516808A
(ja)
*
|
1996-08-05 |
2000-12-19 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
Ｍｈｃ結合ペプチドオリゴマーおよび使用方法
|
|
US6368598B1
(en)
*
|
1996-09-16 |
2002-04-09 |
Jcrt Radiation Oncology Support Services, Inc. |
Drug complex for treatment of metastatic prostate cancer
|
|
KR100518903B1
(ko)
|
1996-10-25 |
2005-10-06 |
미네소타 마이닝 앤드 매뉴팩춰링 캄파니 |
Ｔｈ2 매개 질병 및 관련 질병의 치료용 면역 반응 조절 화합물
|
|
US6211159B1
(en)
|
1997-04-11 |
2001-04-03 |
University Of Toronto |
Flagellin gene, FlaC of campylobacter
|
|
US6060082A
(en)
*
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
|
US5837752A
(en)
|
1997-07-17 |
1998-11-17 |
Massachusetts Institute Of Technology |
Semi-interpenetrating polymer networks
|
|
DK1017721T3
(da)
*
|
1997-09-16 |
2009-04-20 |
Univ Oregon Health & Science |
Rekombinante MHC molekyler, der kan anvendes til manipulation af antigenspecifikke T-celler
|
|
NZ504800A
(en)
|
1997-11-28 |
2001-10-26 |
Sumitomo Pharma |
6-Amino-9-benzyl-8-hydroxy-purine derivatives and interferon inducers, antiviral agents, anticancer agents and therapeutic agents for immunologic diseases thereof
|
|
US6254890B1
(en)
*
|
1997-12-12 |
2001-07-03 |
Massachusetts Institute Of Technology |
Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids
|
|
US6197229B1
(en)
*
|
1997-12-12 |
2001-03-06 |
Massachusetts Institute Of Technology |
Method for high supercoiled DNA content microspheres
|
|
US6632922B1
(en)
|
1998-03-19 |
2003-10-14 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6686446B2
(en)
|
1998-03-19 |
2004-02-03 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6506577B1
(en)
|
1998-03-19 |
2003-01-14 |
The Regents Of The University Of California |
Synthesis and crosslinking of catechol containing copolypeptides
|
|
GB9808932D0
(en)
*
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
|
CA2685270C
(en)
*
|
1998-05-13 |
2014-07-29 |
Pharmexa Inc. |
Expression vectors for stimulating an immune response and methods of using the same
|
|
EP1388586A3
(en)
*
|
1998-05-29 |
2004-05-26 |
Epimmune Inc. |
Identification of broadly reactive DR restricted epitopes
|
|
AU4224499A
(en)
*
|
1998-05-29 |
1999-12-13 |
Epimmune, Inc. |
Identification of broadly reactive dr restricted epitopes
|
|
US6306640B1
(en)
*
|
1998-10-05 |
2001-10-23 |
Genzyme Corporation |
Melanoma antigenic peptides
|
|
IL141868A0
(en)
*
|
1998-10-05 |
2002-03-10 |
M & E Biotech As |
Novel methods for therapeutic vaccination
|
|
DE69935606T9
(de)
*
|
1998-10-16 |
2021-03-11 |
Glaxosmithkline Biologicals S.A. |
Adjuvanzsysteme und impfstoffe
|
|
US6232082B1
(en)
*
|
1998-12-01 |
2001-05-15 |
Nabi |
Hapten-carrier conjugates for treating and preventing nicotine addiction
|
|
DE60014076T2
(de)
*
|
1999-04-19 |
2005-10-13 |
Glaxosmithkline Biologicals S.A. |
Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
|
|
US7238368B2
(en)
*
|
1999-04-23 |
2007-07-03 |
Alza Corporation |
Releasable linkage and compositions containing same
|
|
US7390780B2
(en)
*
|
1999-04-23 |
2008-06-24 |
Alza Corporation |
Gene delivery mediated by liposome-DNA complex with cleavable peg surface modification
|
|
KR100669053B1
(ko)
*
|
1999-04-23 |
2007-01-15 |
알자 코포레이션 |
리포좀에 사용하기 위한 절단가능 결합을 갖는 콘쥬게이트
|
|
US6800296B1
(en)
*
|
1999-05-19 |
2004-10-05 |
Massachusetts Institute Of Technology |
Modification of surfaces using biological recognition events
|
|
US7223398B1
(en)
|
1999-11-15 |
2007-05-29 |
Dynavax Technologies Corporation |
Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
|
|
JP4751556B2
(ja)
|
2000-02-28 |
2011-08-17 |
ジーンシーグス， インコーポレイテッド |
ナノカプセルカプセル化システムおよび方法
|
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
|
US20020165176A1
(en)
*
|
2000-05-01 |
2002-11-07 |
Haynes Joel R. |
Nucleic acid immunization
|
|
CA2407897A1
(en)
*
|
2000-05-05 |
2001-11-15 |
Cytos Biotechnology Ag |
Molecular antigen arrays and vaccines
|
|
US7192725B2
(en)
|
2000-05-19 |
2007-03-20 |
University Of Toronto |
Flagellin gene, flaC of Campylobacter
|
|
GB0025414D0
(en)
|
2000-10-16 |
2000-11-29 |
Consejo Superior Investigacion |
Nanoparticles
|
|
US7097837B2
(en)
*
|
2001-02-19 |
2006-08-29 |
Pharmexa A/S |
Synthetic vaccine agents
|
|
US20030175950A1
(en)
*
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
|
US6818732B2
(en)
|
2001-08-30 |
2004-11-16 |
The Regents Of The University Of California |
Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
|
|
US8153141B2
(en)
|
2002-04-04 |
2012-04-10 |
Coley Pharmaceutical Gmbh |
Immunostimulatory G, U-containing oligoribonucleotides
|
|
FR2840499B1
(fr)
*
|
2002-05-30 |
2004-12-10 |
Cit Alcatel |
Procede et dispositif de controle d'acces a un reseau local de communications sans fil
|
|
AU2003302226A1
(en)
*
|
2002-09-24 |
2004-06-30 |
University Of Kentucky Research Foundation |
Nanoparticle-based vaccine delivery system containing adjuvant
|
|
CA2502268A1
(en)
*
|
2002-10-23 |
2004-05-06 |
Glaxosmithkline Biologicals S.A. |
Methods for vaccinating against malaria
|
|
WO2004063963A2
(en)
*
|
2003-01-08 |
2004-07-29 |
Xencor, Inc. |
Novel proteins with altered immunogenicity
|
|
WO2004071493A1
(en)
*
|
2003-02-17 |
2004-08-26 |
Peter Burkhard |
Peptidic nanoparticles as drug delivery and antigen display systems
|
|
US7727969B2
(en)
*
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
|
EP1651258B1
(en)
*
|
2003-07-30 |
2014-03-19 |
Vaccine Research Institute of San Diego |
Hepatitis virus core proteins as vaccine platforms and methods of use thereof
|
|
US20050137156A1
(en)
*
|
2003-08-09 |
2005-06-23 |
Johnston Stephen A. |
Methods and compositions for generating an immune response
|
|
US20080160089A1
(en)
*
|
2003-10-14 |
2008-07-03 |
Medivas, Llc |
Vaccine delivery compositions and methods of use
|
|
DE10347710B4
(de)
*
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
|
DK1704585T3
(en)
|
2003-12-19 |
2017-05-22 |
Univ North Carolina Chapel Hill |
Methods for preparing isolated micro- and nanostructures using soft lithography or printing lithography
|
|
WO2005097993A2
(en)
|
2004-02-19 |
2005-10-20 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory viral rna oligonucleotides
|
|
AU2005250170A1
(en)
*
|
2004-06-01 |
2005-12-15 |
Genimmune N.V. |
Peptides for inducing a CTL and/or HTL response to hepatitis C virus
|
|
JP2008512350A
(ja)
|
2004-07-01 |
2008-04-24 |
イェール ユニバーシティ |
標的化され、そして高密度で薬物が負荷されるポリマー性物質
|
|
US20080206270A1
(en)
*
|
2004-07-08 |
2008-08-28 |
Minev Boris R |
Enhancing Class I Antigen Presentation With Synthetic Sequences
|
|
US8017151B2
(en)
*
|
2004-09-07 |
2011-09-13 |
Board Of Regents Of The University Of Nebraska By And Behalf Of The University Of Nebraska Medical Center |
Amphiphilic polymer-protein conjugates and methods of use thereof
|
|
US9079765B2
(en)
*
|
2004-10-01 |
2015-07-14 |
Midatech Ltd. |
Nanoparticles comprising antigens and adjuvants, and immunogenic structures
|
|
WO2006042333A2
(en)
*
|
2004-10-12 |
2006-04-20 |
Xencor, Inc. |
Prediction and assessment of immunogenicity
|
|
MY159370A
(en)
|
2004-10-20 |
2016-12-30 |
Coley Pharm Group Inc |
Semi-soft-class immunostimulatory oligonucleotides
|
|
US9492400B2
(en)
*
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
US20090162400A1
(en)
*
|
2004-12-21 |
2009-06-25 |
Powell Thomas J |
Compositions of influenza viral proteins and methods of use thereof
|
|
JP5224821B2
(ja)
*
|
2005-02-01 |
2013-07-03 |
アメリカ合衆国 |
広範に交差中和する抗体を誘導するためのパピローマウイルスｌ２ｎ末端ペプチド
|
|
WO2006116458A2
(en)
|
2005-04-26 |
2006-11-02 |
Coley Pharmaceutical Gmbh |
Modified oligoribonucleotide analogs with enhances immunostimulatory activity
|
|
JP2009512421A
(ja)
*
|
2005-08-15 |
2009-03-26 |
ヴァクシン インコーポレイテッド |
非複製性ベクターワクチン投与による鳥類への免疫方法
|
|
PL1957647T3
(pl)
|
2005-11-25 |
2015-07-31 |
Zoetis Belgium S A |
Oligorybonukleotydy immunostymulujące
|
|
WO2007089607A2
(en)
*
|
2006-01-26 |
2007-08-09 |
University Of Massachusetts |
Rna silencing agents for use in therapy and nanotransporters for efficient delivery of same
|
|
US8367113B2
(en)
*
|
2006-05-15 |
2013-02-05 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
|
US20110052697A1
(en)
*
|
2006-05-17 |
2011-03-03 |
Gwangju Institute Of Science & Technology |
Aptamer-Directed Drug Delivery
|
|
WO2008033432A2
(en)
|
2006-09-12 |
2008-03-20 |
Coley Pharmaceutical Group, Inc. |
Immune modulation by chemically modified ribonucleosides and oligoribonucleotides
|
|
CA2665090A1
(en)
*
|
2006-09-22 |
2008-03-27 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating mica-related disorders
|
|
AU2008222678B2
(en)
*
|
2007-03-07 |
2013-01-17 |
The General Hospital Corporation |
Compositions and methods for the prevention and treatment of autoimmune conditions
|
|
WO2008124632A1
(en)
*
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Amphiphilic compound assisted nanoparticles for targeted delivery
|
|
CN101765607B
(zh)
*
|
2007-05-31 |
2015-09-09 |
莱顿教学医院 |
侵润宫颈恶性肿瘤的t细胞所靶向的用于疫苗的hpv表位
|
|
KR20100075843A
(ko)
*
|
2007-08-21 |
2010-07-05 |
다이나박스 테크놀로지 코퍼레이션 |
인플루엔자 단백질 조성물 및 그 제조 및 사용 방법
|
|
EP2630966B1
(en)
*
|
2007-10-12 |
2017-04-19 |
Massachusetts Institute of Technology |
Vaccine nanotechnology
|
|
RU2540871C2
(ru)
*
|
2008-02-01 |
2015-02-10 |
Альфа-О Пептидес Аг |
Самоорганизующиеся пептидные наночастицы, полезные в качестве вакцин
|
|
ES2545886T3
(es)
*
|
2008-02-14 |
2015-09-16 |
Life Sciences Research Partners Vzw |
Inmunoterapia dirigida a patógenos intracelulares
|
|
WO2009108807A1
(en)
*
|
2008-02-26 |
2009-09-03 |
The Regents Of The University Of California |
Glycopeptides and methods of making and using them
|
|
KR20120022984A
(ko)
*
|
2009-04-21 |
2012-03-12 |
셀렉타 바이오사이언시즈, 인크. |
Ｔｈ１ 편향 반응을 제공하는 면역나노치료법
|
|
CA2762653A1
(en)
*
|
2009-05-27 |
2010-12-02 |
Selecta Biosciences, Inc. |
Immunomodulatory agent-polymeric compounds
|
|
CN107617110A
(zh)
*
|
2009-08-26 |
2018-01-23 |
西莱克塔生物科技公司 |
诱导t细胞辅助的组合物
|
|
WO2011085231A2
(en)
*
|
2010-01-08 |
2011-07-14 |
Selecta Biosciences, Inc. |
Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines
|
|
US20110262491A1
(en)
*
|
2010-04-12 |
2011-10-27 |
Selecta Biosciences, Inc. |
Emulsions and methods of making nanocarriers
|
|
AU2011258165B2
(en)
*
|
2010-05-26 |
2016-11-17 |
Selecta Biosciences, Inc. |
Dose selection of adjuvanted synthetic nanocarriers
|
|
US20120058153A1
(en)
*
|
2010-08-20 |
2012-03-08 |
Selecta Biosciences, Inc. |
Synthetic nanocarrier vaccines comprising proteins obtained or derived from human influenza a virus hemagglutinin
|
|
BR112013004288A2
(pt)
*
|
2010-08-23 |
2016-05-31 |
Selecta Biosciences Inc |
formas galênicas de múltiplos epítopos direcionados para indução de uma resposta imunológica a antigênios.
|
|
WO2012061717A1
(en)
*
|
2010-11-05 |
2012-05-10 |
Selecta Biosciences, Inc. |
Modified nicotinic compounds and related methods
|
|
WO2012092552A1
(en)
*
|
2010-12-30 |
2012-07-05 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers with reactive groups that release biologically active agents
|
|
CA2830948A1
(en)
*
|
2011-03-25 |
2012-10-04 |
Selecta Biosciences, Inc. |
Osmotic mediated release synthetic nanocarriers
|
|
KR20140041505A
(ko)
*
|
2011-04-29 |
2014-04-04 |
셀렉타 바이오사이언시즈, 인크. |
조절 b 세포 유도를 위한 관용원성 합성 나노운반체
|
|
JP2014521687A
(ja)
*
|
2011-07-29 |
2014-08-28 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
体液性および細胞傷害性ｔリンパ球（ｃｔｌ）免疫応答を生成する合成ナノキャリア
|
|
US20130058901A1
(en)
*
|
2011-09-06 |
2013-03-07 |
Selecta Biosciences, Inc. |
Transplantable graft-specific induced tolerogenic dendritic cells and methods of use
|